What's in Wuhan Createrna Science and Technology Co., Ltd's pipeline?

Wuhan Createrna Science and Technology Co., Ltd has 2 drugs in our index: 0 marketed, 0 filed, 2 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Wuhan Createrna Science and Technology Co., Ltd's portfolio?

Top competitors by shared drug class: Alexion Pharmaceuticals, Inc., Bausch & Lomb Incorporated, Massachusetts General Hospital, University Hospital, Tours.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/wuhan-createrna-science-and-technology-co-ltd.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Wuhan Createrna Science and Technology Co., Ltd — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Wuhan Createrna Science and Technology Co., Ltd pipeline: 0 marketed, 0 filed, 2 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 2 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
MY008211A tablets	MY008211A tablets	phase 3
Eculizumab Injection	Eculizumab Injection	phase 3	Complement C5 inhibitor	C5 (Complement protein 5)	Immunology

Therapeutic area mix

Immunology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Alexion Pharmaceuticals, Inc. · 1 shared drug class
Bausch & Lomb Incorporated · 1 shared drug class
Massachusetts General Hospital · 1 shared drug class
University Hospital, Tours · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Wuhan Createrna Science and Technology Co., Ltd:

Cite this brief

Drug Landscape (2026). Wuhan Createrna Science and Technology Co., Ltd — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/wuhan-createrna-science-and-technology-co-ltd. Accessed 2026-05-17.